ArticleInternational journal of hematology2026

Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study).

Ryota Imanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.